<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Genomics</journal-id>
    <journal-title-group>
      <journal-title>BMC Genomics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2164</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10464125</article-id>
    <article-id pub-id-type="pmid">37620754</article-id>
    <article-id pub-id-type="publisher-id">9599</article-id>
    <article-id pub-id-type="doi">10.1186/s12864-023-09599-5</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Database</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>GMMAD: a comprehensive database of human gut microbial metabolite associations with diseases</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Cheng-Yu</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kuang</surname>
          <given-names>Xia</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Qiao-Qiao</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Gu-Qin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cheng</surname>
          <given-names>Zhen-Shun</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Deng</surname>
          <given-names>Zi-Xin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Guo</surname>
          <given-names>Feng-Biao</given-names>
        </name>
        <address>
          <email>fbguoy@whu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01v5mqw79</institution-id><institution-id institution-id-type="GRID">grid.413247.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 1808 0969</institution-id><institution>Department of Respiratory and Critical Care Medicine, </institution><institution>Zhongnan Hospital of Wuhan University, </institution></institution-wrap>Wuhan, China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/033vjfk17</institution-id><institution-id institution-id-type="GRID">grid.49470.3e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2331 6153</institution-id><institution>Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education and School of Pharmaceutical Sciences, </institution><institution>Wuhan University, </institution></institution-wrap>Wuhan, China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>24</day>
      <month>8</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>24</day>
      <month>8</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>24</volume>
    <elocation-id>482</elocation-id>
    <history>
      <date date-type="received">
        <day>9</day>
        <month>2</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>17</day>
        <month>8</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">The natural products, metabolites, of gut microbes are crucial effect factors on diseases. Comprehensive identification and annotation of relationships among disease, metabolites, and microbes can provide efficient and targeted solutions towards understanding the mechanism of complex disease and development of new markers and drugs.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">We developed <bold>G</bold>ut <bold>M</bold>icrobial <bold>M</bold>etabolite <bold>A</bold>ssociation with <bold>D</bold>isease (GMMAD), a manually curated database of associations among human diseases, gut microbes, and metabolites of gut microbes. Here, this initial release (i) contains 3,836 disease-microbe associations and 879,263 microbe-metabolite associations, which were extracted from literatures and available resources and then experienced our manual curation; (ii) defines an association strength score and a confidence score. With these two scores, GMMAD predicted 220,690 disease-metabolite associations, where the metabolites all belong to the gut microbes. We think that the positive effective (with both scores higher than suggested thresholds) associations will help identify disease marker and understand the pathogenic mechanism from the sense of gut microbes. The negative effective associations would be taken as biomarkers and have the potential as drug candidates. Literature proofs supported our proposal with experimental consistence; (iii) provides a user-friendly web interface that allows users to browse, search, and download information on associations among diseases, metabolites, and microbes. The resource is freely available at <ext-link ext-link-type="uri" xlink:href="http://guolab.whu.edu.cn/GMMAD">http://guolab.whu.edu.cn/GMMAD</ext-link>.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">As the online-available unique resource for gut microbial metabolite-disease associations, GMMAD is helpful for researchers to explore mechanisms of disease- metabolite-microbe and screen the drug and marker candidates for different diseases.</p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s12864-023-09599-5.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Disease</kwd>
      <kwd>Metabolite</kwd>
      <kwd>Microbe</kwd>
      <kwd>Association score</kwd>
      <kwd>GMMAD database</kwd>
    </kwd-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© BioMed Central Ltd., part of Springer Nature 2023</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par4">Our gut harbours trillions of microbes which play essential roles in many physiological and pathological processes. The disturbances of gut microbiome homeostasis can cause many diseases. For example, the enrichment of <italic>Fusobacterium nucleatum</italic> can induce colorectal cancer metastasis [<xref ref-type="bibr" rid="CR1">1</xref>]. Many other diseases are also affected by microbes, such as Parkinson disease and diabetes, yet their mechanisms are still unclear [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Thanks to advances in technologies such as sequencing, we are now able to observe and analyse the composition and status of gut microbes. This can help us to diagnose diseases early and even propose new treatments based on the increase and decrease of different microbial populations in diseases [<xref ref-type="bibr" rid="CR4">4</xref>]. Although numerous studies uncover the mechanism among diseases, microbes, and metabolites, these associations are still scattered in the literature [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
    <p id="Par5">In recent decades, more and more studies have shown that microbes affect human health through their metabolites [<xref ref-type="bibr" rid="CR6">6</xref>]. The metabolite is one of the key factors that drive the interaction between human gut microbes and diseases. For example, Trimethylamine N-oxide (TMAO) is a metabolite derived from the gut microbiota, which has been widely reported to be associated with cardiovascular disease [<xref ref-type="bibr" rid="CR7">7</xref>]. Recently, some studies also reported that TMAO might be a key activator of antitumor immunity [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Another metabolite associated with cardiovascular disease is phenylacetylglutamine (PAGln). Stanley L. Hazen et al. found gut microbes that converted dietary phenylalanine into phenylacetic acid. Then, they combined with Gln and generated the PAGln. PAGln could enhance platelet activation and be associated with adverse cardiovascular events such as myocardial infarction and stroke [<xref ref-type="bibr" rid="CR10">10</xref>]. Based on these findings, the metabolites are believed to have the potential to act as drugs of various disease, and the disruption of metabolites also identified as signatures of many diseases.</p>
    <p id="Par6">Some resources focused on the association of disease-microbe or microbe-metabolite. For example, HMDAD collect text-mining-based microbe-disease associations from peer-reviewed publications [<xref ref-type="bibr" rid="CR11">11</xref>]. The current version contains 483 disease-microbe entries, which include 39 diseases and 292 microbes. The gutMDisorder is a main repository for dysbiosis of the gut microbiota in disorders and interventions, [<xref ref-type="bibr" rid="CR12">12</xref>] which contains 2,263 associations between 579 gut microbes and 123 disorders or 77 interventions in Human. The mBodyMap is a curated database for tissue microbes’ associations with diseases and health [<xref ref-type="bibr" rid="CR13">13</xref>], which contains a total of 63,148 runs, including 14,401 metagenomes and 48,747 amplicons related to health and 56 human diseases. Some researchers also developed some predicting methods to dig the potential disease-microbe associations. NTSHMDA can predict the human microbe-disease association based on random walk by integrating network topological similarity [<xref ref-type="bibr" rid="CR14">14</xref>]. ABHMDA is a model to reveal the associations between diseases and microbes by calculating the relation probability of a disease-microbe pair using a strong classifier, which can be applied to new disease without any known related microbes [<xref ref-type="bibr" rid="CR15">15</xref>]. Many other methods and models can predict disease-microbe associations [<xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR19">19</xref>]. On the other hand, there are a few resources that store the metabolites of microbes, such as VMH [<xref ref-type="bibr" rid="CR20">20</xref>] and NJS16 [<xref ref-type="bibr" rid="CR21">21</xref>]. However, there is still a shortage of resources of diseases’ associations with metabolites of gut microbes.</p>
    <p id="Par7">To fill this gap, we constructed the Gut Microbial Metabolite Association with Disease (GMMAD), which aims to provide users comprehensive metabolism related information of gut microbes in human diseases. Users can easily browse associations among diseases, microbes, and metabolites stored in GMMAD, and screen the potential candidate disease signatures or drugs from our predicted disease-metabolite associations (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). The current version of GMMAD documents the 45,058 meaningful disease-metabolite associations which are predicted and involved with 31 diseases and 2,299 metabolites. We expect GMMAD to be a timely and valuable resource for gut microbes’ research.<fig id="Fig1"><label>Fig. 1</label><caption><p>The process of data collection and database construction. Upper part shows the process of the data collection, including manually curating literature and integrating public databases. The left panel describes our manual extraction of experimental microbe-disease information. The right panel gives the list of public databases of information source. Lower part shows the types of associations, basic information of each association entry and GMMAD functions. The left panel shows the three types of associations. Disease-metabolite is the core association, and it is provided exclusively by our database. The middle panel tells the basic information of each entry, including details of disease description, microbial category, molecular mass of metabolite and so on. The right panel provides a list of GMMAD’s main functions</p></caption><graphic xlink:href="12864_2023_9599_Fig1_HTML" id="MO1"/></fig></p>
  </sec>
  <sec id="Sec2">
    <title>Materials and methods</title>
    <sec id="Sec3">
      <title>Data collection for the first two associations</title>
      <p id="Par8">All the names of diseases in GMMAD followed the principle from the Medical Subject Heading disease categories [<xref ref-type="bibr" rid="CR22">22</xref>], and it contained 113 diseases. The annotation information of microbes was collected from the Taxonomy database [<xref ref-type="bibr" rid="CR23">23</xref>]. All the metabolites’ details were obtained from the PubChem database [<xref ref-type="bibr" rid="CR24">24</xref>]. For the association data, we integrated several public databases. The disease-microbe associations were collected from HMDAD, gutMDisorder, and Peryton [<xref ref-type="bibr" rid="CR25">25</xref>]. All data from other public databases should meet the naming standards of disease (MeSH), microbe (ncbi Taxonomy) and metabolite (PubChem). Because most of the current sequencing technologies for microbes, such as metagenomic sequencing and 16sRNA sequencing, can accurately identify only at the genus level, the microbes in our disease-microbe associations are all defined on the genus level. The microbe-metabolite associations were obtained from VMH [<xref ref-type="bibr" rid="CR20">20</xref>], NJS16 [<xref ref-type="bibr" rid="CR21">21</xref>], and the study of Han S. et al. [<xref ref-type="bibr" rid="CR6">6</xref>]. The microbes collected from VMH were in the strain level. We map the genus level of gut microbes for disease-microbe association to the strain level of metabolite-microbe association based on lineage data obtained from Taxonomy. In detail, if microbes were found to increase\decrease under the genus level in a particular disease, then it is assumed that all strains included in that genus have increased/decreased at the disease status. For example, if <italic>Faecalibacterium</italic> (in genus level) is decreased in obesity, it is assumed that the <italic>Faecalibacterium cf. prausnitzii KLE1255</italic> and <italic>Faecalibacterium prausnitzii A2-165</italic> (two strains of microbes belonging to <italic>Faecalibacterium</italic>) were both decreased in obesity. Furthermore, we used the keywords combination to search related literatures in PubMed, such as ‘gut microbiota AND cancer AND metabolites’, ‘intestinal microbiota AND diabetes AND metabolites’, etc. Then, we downloaded all published literature and available <xref rid="MOESM1" ref-type="media">supplementary files</xref> describing the associations among diseases, microbes, and metabolites. Finally, we manually extracted experimentally supported associations from selected articles by at least two researchers. For all the association, we removed the contradictory entries to ensure that the data in GMMAD were harmonious. The redundant entries stored in the GMMAD database were removed (upper part of Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Values of the above two association are discrete with the first one having two directions and the latter one being “appearing” or “deficiency”. For the latter one, we only record those metabolites appearing in one specific microbe.</p>
    </sec>
    <sec id="Sec4">
      <title>Association strength score and confidence score</title>
      <p id="Par9">For the core disease-metabolite relationships, we defined one quantitative value. We supposed that common metabolites in multiple decreased numbers were beneficial to treat specific human disease, while the ones in multiple increased microbes would promote the development of that disease [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. We defined an association strength score to infer the association between the diseases and metabolites of gut microbes. We defined the number of microbes which increase/decrease in a specific disease as M/N, and the number of the increasing and decreasing microbes which generated a specific metabolite as m/n. The formula for the association strength score is:<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{as}= \frac{m}{M}-\frac{n}{N}$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">as</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mi>m</mml:mi><mml:mi>M</mml:mi></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:mi>n</mml:mi><mml:mi>N</mml:mi></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="12864_2023_9599_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par10">Meanwhile, we defined a confidence score to judge the credibility of association strength scores:<disp-formula id="Equb"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{ac}=\left(m+n\right)*\left|{S}_{as}\right|$$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">ac</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mi>m</mml:mi><mml:mo>+</mml:mo><mml:mi>n</mml:mi></mml:mfenced><mml:mrow/><mml:mo>∗</mml:mo><mml:mfenced close="|" open="|"><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">as</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12864_2023_9599_Article_Equb.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par11">Because the microbial levels in the two associations were inconsistent (disease-microbe with genus level and microbe-metabolite with strain level), we used the affiliation data of microbial lineage (finally, microbe in strain level) to establish the association. <inline-formula id="IEq1"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{\mathrm{as}}$$\end{document}</tex-math><mml:math id="M6"><mml:msub><mml:mi>S</mml:mi><mml:mi mathvariant="normal">as</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12864_2023_9599_Article_IEq1.gif"/></alternatives></inline-formula> of three and five diseases are all 1 and -1, respectively. After checking, it was found that only one microbe associated with these diseases, such as ‘Colitis, Microscopic’ and ‘Gastroesophageal Reflux’. <inline-formula id="IEq2"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{\mathrm{as}}$$\end{document}</tex-math><mml:math id="M8"><mml:msub><mml:mi>S</mml:mi><mml:mi mathvariant="normal">as</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12864_2023_9599_Article_IEq2.gif"/></alternatives></inline-formula> simulated the abundant alternation of a specific metabolite by counting the increasing or decreasing number of microbial strains in a disease sample compared to a normal sample’s gut. If a metabolite appears in only decreased microbes, its association score <inline-formula id="IEq3"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{ac}$$\end{document}</tex-math><mml:math id="M10"><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">ac</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12864_2023_9599_Article_IEq3.gif"/></alternatives></inline-formula> will have a very large negative value and in principle, it will be beneficial for the treatment of the disease or at least strongly associated with the disease. Hence, a strong positive correlation score indicated that the metabolite might be considered as a potential marker of disease, while a strong negative correlation score indicated that the metabolite might be a candidate drug for disease or potential diagnostic marker. We only considered those with the absolute value of association strength score &gt; 0.05 and confidence score &gt; 1 to be meaningful.</p>
    </sec>
    <sec id="Sec5">
      <title>Database construction</title>
      <p id="Par12">Finally, all data in GMMAD are stored and managed using MySQL (version 5.6.50). The web interfaces were built in HTML/CSS/JS on Linux and Apache platform. The data processing programs are written in Python (version 2.7.5). The GMMAD has been tested in the Google Chrome (version 104.0.5112.81) and Firefox (version 101.0.1) browsers. The GMMAD database is freely available at <ext-link ext-link-type="uri" xlink:href="http://guolab.whu.edu.cn/GMMAD">http://guolab.whu.edu.cn/GMMAD</ext-link>.</p>
    </sec>
  </sec>
  <sec id="Sec6">
    <title>Results</title>
    <sec id="Sec7">
      <title>Database content</title>
      <p id="Par13">With our method, we predicted 220,690 entries of disease-metabolite associations, the confidence scores are distributed from -1 to 1 (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Integrating and compiling all the associations we obtained from public databases and papers, GMMAD contains 3,836 disease-microbe associations and 879,263 microbe-metabolite associations which involve 113 diseases, 893 gut microbes, and 2,448 metabolites of gut microbes (Fig. <xref rid="Fig3" ref-type="fig">3</xref>A). Finally, there are 45,058 meaningful disease-metabolite associations by scoring prediction, which involve 31 diseases and 2,299 metabolites. Since each microbe produces thousands of metabolites and each disease has hundreds of associated microbes, the number of associations for the three elements disease-microbe-metabolite is huge. Showing all these associations is not helpful for user search, and it is hard for database maintenance. Thus, GMMAD only shows associations between any two of the three terms: disease, microbe and metabolite. For each entry, GMMAD restored the human disease name (e.g. Crohn disease), microbe name (e.g. <italic>Faecalibacterium</italic>), metabolite name (e.g. Actinomyces georgiae DSM 6843), alteration pattern (e.g. increase and decrease), the experimental method (e.g. 16S rRNA sequences), alteration strength score and confidence score of disease-metabolite associations, disease detail (e.g. disease description), metabolite information (e.g. charged formula, average molecular mass), and microbe information. The ID of disease, microbe, metabolite and PMID were also provided which could be linked to MeSH, Taxonomy, PubChem and PubMed for more details.<fig id="Fig2"><label>Fig. 2</label><caption><p>Distribution of association strength scores in 113 different diseases. Diseases were shown in the deceasing order of the mean <italic>S</italic><sub><italic>as</italic></sub> of associated metabolites</p></caption><graphic xlink:href="12864_2023_9599_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Statistic of data in GMMAD. <bold>A</bold> The number of diseases, microbes and metabolites in GMMAD. <bold>B</bold> The top 10 diseases in disease-microbe associations. <bold>C</bold> The top 10 microbes in disease-microbe associations. <bold>D</bold> The top 10 microbes in microbe-metabolite associations. <bold>E</bold> The top 10 metabolite s in microbe-metabolite associations</p></caption><graphic xlink:href="12864_2023_9599_Fig3_HTML" id="MO3"/></fig></p>
      <p id="Par14">Figure <xref rid="Fig3" ref-type="fig">3</xref>B-E show the top 10 diseases, microbes, and metabolites in the different types of associations. The colorectal neoplasm is the disease with the most entries (Fig. <xref rid="Fig3" ref-type="fig">3</xref>B). This suggested that colorectal neoplasm is closely connected to gut microbes and their metabolites. <italic>Bacteroides</italic> are the microbe which associated with the most diseases (Fig. <xref rid="Fig3" ref-type="fig">3</xref>C). In addition, <italic>Yokenella regensburgei ATCC 43003</italic> and ala_L (L-Alanine) are the microbe and metabolite with the most entries in microbe-metabolite associations (Fig. <xref rid="Fig3" ref-type="fig">3</xref>D, E)<italic>.</italic></p>
    </sec>
    <sec id="Sec8">
      <title>GMMAD implementation</title>
      <p id="Par15">The GMMAD provides a user-friendly interface that allows users to browse, search, and download (lower part of Fig. <xref rid="Fig1" ref-type="fig">1</xref>). The tree browser organizes the data according to three types of associations: “Disease-Metabolite”, “Disease-Microbe” and “Microbe-Metabolite”. Each type of root category is divided into several sub-categories named “Disease”, “Metabolite”, “Microbe” and “Validated associations” (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). By clicking one term in these sub-categories, all associations belonging to the corresponding term would be listed on the right table. On the ‘Search’ page, users can search associations according to name and ID of diseases, microbes, and metabolites (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). Example names for searching are provided when users click the “Example” on the bottom of each search box. In the results table, users can click the icon in the upper right corner to download the search results. The ‘Detail’ link of each entry leads to the more detailed information including the microbes’ family, description of diseases, formula of metabolites, samples information and so on (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). The ‘Download’ page allows users to download all information on disease-metabolite, disease-microbe and microbe-metabolite associations data in.txt format. GMMAD also provides external links to the related public databases. All tutorials and details are shown in the ‘Help’ page.<fig id="Fig4"><label>Fig. 4</label><caption><p>Schematic workflow of GMMAD. Browse part: User can browse all three types of association data in GMMAD. Search part: User can search the interested association by typing the key word. Results part: All the results will be shown in the table which includes information about each term. Details part: User can click ‘Detail’ to obtain more details about disease, microbe, and metabolite</p></caption><graphic xlink:href="12864_2023_9599_Fig4_HTML" id="MO4"/></fig></p>
    </sec>
    <sec id="Sec9">
      <title>Validation of predicted disease-metabolite association</title>
      <p id="Par16">To prioritize and filter the meaning of disease-metabolite association and reveal the most interesting results, we defined an association strength score and a confidence score. As a rough evaluation of the accuracy of our method, we got 138 experimental disease-metabolite association from 49 published studies. Among them, 36 associations have meaning scores and 26 (72.2%) could be given consistent direction of disease-metabolite association (Supplementary table <xref rid="MOESM1" ref-type="media">1</xref>). We do not aim to pick out all the disease-metabolites associations, and our main purpose is to make our chosen association genuine in high probability and deserved to be studied as drug or marker candidates.</p>
      <p id="Par17">For example, by querying “Diabetes Mellitus, Type 2” (T2DM) in the “Search (Disease-Metabolite)” query box, GMMAD provides the 2137 T2DM associated metabolites. Each entry has an association strength score and a confidence score, which the user can browse in order of score value. For example, we sort all the “Diabetes Mellitus, Type 2” related entries according to their association strength scores, and the “nadide” is the third strongest negative association score with the T2DM (<italic>S</italic><sub><italic>as</italic></sub> = -0.625 and <italic>S</italic><sub><italic>ac</italic></sub> = 3.13). Nadide (also called NAD + , Nicotinamide Adenine Dinucleotide) is an indispensable enzyme in the human body and an important coenzyme in the tricarboxylic acid cycle. It plays a crucial role in various biological processes such as human metabolism, stress, and cell differentiation. In patients with T2DM, NAD + synthesis is severely impaired [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Many researchers are trying to promote the synthesis of NAD + as a treatment for patients with type 2 diabetes mellitus, and several drugs based on this mechanism have been developed [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Similarly, the “Melatonin” is the fifth strongest negative association score with the T2DM (S<sub>as</sub> = -0.500 and S<sub>ac</sub> = 2.00). Melatonin is well known for its sleep-promoting effects. In recent years, studies had found that melatonin has a certain hypoglycaemic effect, and its mechanism might be related to improving insulin resistance, protecting pancreatic β-cells, and regulating the hypothalamus–pituitary–adrenal axis. These findings reveal the importance of melatonin and melatonin-related bacteria and metabolites as potential therapeutic targets for type 2 diabetes [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. All of these demonstrate that our method can effectively expose the useful disease-metabolite associations.</p>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Discussion</title>
    <p id="Par18">Despite a lot of research on the association between gut microbes and diseases, the mechanism of gut microbes in various diseases is still unclear. In recent years, more and more researchers have found that gut microbes affect through their metabolites in diseases [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>].</p>
    <p id="Par19">Currently, there are many disease-microbe databases have been built, such as HMDAD [<xref ref-type="bibr" rid="CR11">11</xref>], gutMDisorder [<xref ref-type="bibr" rid="CR12">12</xref>] and Peryton [<xref ref-type="bibr" rid="CR25">25</xref>]. To the best of our knowledge, none of these databases focuses on the association data of disease and metabolites of gut microbes. However, the current version of our GMMAD contains 45,058 meaningful disease-metabolite associations.</p>
    <p id="Par20">As the resource uniquely stores the quantitative association of disease and gut microbes’ metabolites, GMMAD will suggest potential markers and drugs for specific diseases. When used as drug candidates for these metabolites, the safety of these candidates will be less concerning than usual drug candidates because they naturally exist in the human gut environment. Simultaneously, the association due to their predictive essence should be experimentally validated by the research in practical application. The role of our database is to pick out those most possible drug and biomarker candidate from the gut microbes’ metabolites and ranked them with quantitative scores. By referencing our database, the experimental scientists have the refined candidates in their hands, and they deserve to pay more attention. With the accumulation of data, the one sense is the promotion of associations between the disease and microbial strains, the other sense is that the metabolome research could provide more reliable microbe-metabolite associations. We will update the database with a higher quality list of associations between specific disease and metabolites of gut microbes. In the future, besides the content update, more features will be added to the database, such as the ability to search for broad chemical classes of compounds beyond specific compounds. Meanwhile, we will provide visualization tools for showing the associations network.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <sec id="Sec11">
      <title>Supplementary Information</title>
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12864_2023_9599_MOESM1_ESM.docx">
            <caption>
              <p><bold>Additional file 1: </bold><bold>Supplementary Table 1.</bold> Predictive scores of experimentally validated disease-metabolite association data.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>Not applicable.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>FBG conceived the study and guided it throughout and revised the manuscript. CYW, XK, and QQW performed the dataset collection. CYW compiled the codes for the database and prepared the figures and tables and wrote the first draft of the manuscript. GQZ, ZSC and ZXD contributed to the review of the manuscript before submission. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This study was supported by the National Key Research and Development Program [2018YFA0903702].</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>GMMAD is publicly available: <ext-link ext-link-type="uri" xlink:href="http://guolab.whu.edu.cn/GMMAD">http://guolab.whu.edu.cn/GMMAD</ext-link>.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par21">Not applicable.</p>
    </notes>
    <notes id="FPar2" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par22">The authors declare no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ge</surname>
            <given-names>Q</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7</article-title>
        <source>Gut Microbes</source>
        <year>2020</year>
        <volume>11</volume>
        <issue>3</issue>
        <fpage>511</fpage>
        <lpage>525</lpage>
        <pub-id pub-id-type="doi">10.1080/19490976.2019.1695494</pub-id>
        <?supplied-pmid 31910722?>
        <pub-id pub-id-type="pmid">31910722</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Massey</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>The gut microbial endocrine organ in type 2 diabetes</article-title>
        <source>Endocrinology</source>
        <year>2021</year>
        <volume>162</volume>
        <issue>2</issue>
        <fpage>bqaa235</fpage>
        <pub-id pub-id-type="doi">10.1210/endocr/bqaa235</pub-id>
        <?supplied-pmid 33373432?>
        <pub-id pub-id-type="pmid">33373432</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tan</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Lang</surname>
            <given-names>AE</given-names>
          </name>
        </person-group>
        <article-title>The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic</article-title>
        <source>Nat Rev Neurol</source>
        <year>2022</year>
        <volume>18</volume>
        <issue>8</issue>
        <fpage>476</fpage>
        <lpage>495</lpage>
        <pub-id pub-id-type="doi">10.1038/s41582-022-00681-2</pub-id>
        <?supplied-pmid 35750883?>
        <pub-id pub-id-type="pmid">35750883</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Role and Mechanism of Gut Microbiota in Human Disease</article-title>
        <source>Front Cell Infect Microbiol</source>
        <year>2021</year>
        <volume>11</volume>
        <fpage>625913</fpage>
        <pub-id pub-id-type="doi">10.3389/fcimb.2021.625913</pub-id>
        <?supplied-pmid 33816335?>
        <pub-id pub-id-type="pmid">33816335</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dang</surname>
            <given-names>AT</given-names>
          </name>
          <name>
            <surname>Marsland</surname>
            <given-names>BJ</given-names>
          </name>
        </person-group>
        <article-title>Microbes, metabolites, and the gut-lung axis</article-title>
        <source>Mucosal Immunol</source>
        <year>2019</year>
        <volume>12</volume>
        <issue>4</issue>
        <fpage>843</fpage>
        <lpage>850</lpage>
        <pub-id pub-id-type="doi">10.1038/s41385-019-0160-6</pub-id>
        <?supplied-pmid 30976087?>
        <pub-id pub-id-type="pmid">30976087</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Han</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Van Treuren</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Fischer</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Merrill</surname>
            <given-names>BD</given-names>
          </name>
          <name>
            <surname>DeFelice</surname>
            <given-names>BC</given-names>
          </name>
          <name>
            <surname>Sanchez</surname>
            <given-names>JM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A metabolomics pipeline for the mechanistic interrogation of the gut microbiome</article-title>
        <source>Nature</source>
        <year>2021</year>
        <volume>595</volume>
        <issue>7867</issue>
        <fpage>415</fpage>
        <lpage>420</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-021-03707-9</pub-id>
        <?supplied-pmid 34262212?>
        <pub-id pub-id-type="pmid">34262212</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Klipfell</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Bennett</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Koeth</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Levison</surname>
            <given-names>BS</given-names>
          </name>
          <name>
            <surname>Dugar</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease</article-title>
        <source>Nature</source>
        <year>2011</year>
        <volume>472</volume>
        <issue>7341</issue>
        <fpage>57</fpage>
        <lpage>63</lpage>
        <pub-id pub-id-type="doi">10.1038/nature09922</pub-id>
        <?supplied-pmid 21475195?>
        <pub-id pub-id-type="pmid">21475195</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Rong</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer</article-title>
        <source>Cell Metab</source>
        <year>2022</year>
        <volume>34</volume>
        <issue>4</issue>
        <fpage>581</fpage>
        <lpage>94 e8</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cmet.2022.02.010</pub-id>
        <?supplied-pmid 35278352?>
        <pub-id pub-id-type="pmid">35278352</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mirji</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Worth</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bhat</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>El Sayed</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Goldman</surname>
            <given-names>AR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer</article-title>
        <source>Sci Immunol</source>
        <year>2022</year>
        <volume>7</volume>
        <issue>75</issue>
        <fpage>eabn0704</fpage>
        <pub-id pub-id-type="doi">10.1126/sciimmunol.abn0704</pub-id>
        <?supplied-pmid 36083892?>
        <pub-id pub-id-type="pmid">36083892</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nemet</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Saha</surname>
            <given-names>PP</given-names>
          </name>
          <name>
            <surname>Gupta</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Romano</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Skye</surname>
            <given-names>SM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors</article-title>
        <source>Cell</source>
        <year>2020</year>
        <volume>180</volume>
        <issue>5</issue>
        <fpage>862</fpage>
        <lpage>7722</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2020.02.016</pub-id>
        <?supplied-pmid 32142679?>
        <pub-id pub-id-type="pmid">32142679</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Geng</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>An analysis of human microbe-disease associations</article-title>
        <source>Brief Bioinform</source>
        <year>2017</year>
        <volume>18</volume>
        <issue>1</issue>
        <fpage>85</fpage>
        <lpage>97</lpage>
        <pub-id pub-id-type="doi">10.1093/bib/bbw005</pub-id>
        <?supplied-pmid 26883326?>
        <pub-id pub-id-type="pmid">26883326</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Qi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zhuang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>gutMDisorder: a comprehensive database for dysbiosis of the gut microbiota in disorders and interventions</article-title>
        <source>Nucleic Acids Res</source>
        <year>2020</year>
        <volume>48</volume>
        <issue>D1</issue>
        <fpage>D554</fpage>
        <lpage>D560</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz843</pub-id>
        <?supplied-pmid 31584099?>
        <pub-id pub-id-type="pmid">31584099</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>mBodyMap: a curated database for microbes across human body and their associations with health and diseases</article-title>
        <source>Nucleic Acids Res</source>
        <year>2022</year>
        <volume>50</volume>
        <issue>D1</issue>
        <fpage>D808</fpage>
        <lpage>D816</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkab973</pub-id>
        <?supplied-pmid 34718713?>
        <pub-id pub-id-type="pmid">34718713</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Luo</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Long</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>NTSHMDA: prediction of human microbe-disease association based on random walk by integrating network topological similarity</article-title>
        <source>IEEE/ACM Trans Comput Biol Bioinform</source>
        <year>2020</year>
        <volume>17</volume>
        <issue>4</issue>
        <fpage>1341</fpage>
        <lpage>1351</lpage>
        <?supplied-pmid 30489271?>
        <pub-id pub-id-type="pmid">30489271</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Peng</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>MX</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Human Microbe-Disease Association Prediction Based on Adaptive Boosting</article-title>
        <source>Front Microbiol</source>
        <year>2018</year>
        <volume>9</volume>
        <fpage>2440</fpage>
        <pub-id pub-id-type="doi">10.3389/fmicb.2018.02440</pub-id>
        <?supplied-pmid 30356751?>
        <pub-id pub-id-type="pmid">30356751</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zou</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>A novel approach for predicting microbe-disease associations by bi-random walk on the heterogeneous network</article-title>
        <source>PLoS ONE</source>
        <year>2017</year>
        <volume>12</volume>
        <issue>9</issue>
        <fpage>e0184394</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0184394</pub-id>
        <?supplied-pmid 28880967?>
        <pub-id pub-id-type="pmid">28880967</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>JF</given-names>
          </name>
        </person-group>
        <article-title>Prediction of microbe-disease associations by graph regularized non-negative matrix factorization</article-title>
        <source>J Comput Biol</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>12</issue>
        <fpage>1385</fpage>
        <lpage>1394</lpage>
        <pub-id pub-id-type="doi">10.1089/cmb.2018.0072</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Niu</surname>
            <given-names>YW</given-names>
          </name>
          <name>
            <surname>Qu</surname>
            <given-names>CQ</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>GH</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>GY</given-names>
          </name>
        </person-group>
        <article-title>RWHMDA: Random Walk on Hypergraph for Microbe-Disease Association Prediction</article-title>
        <source>Front Microbiol</source>
        <year>2019</year>
        <volume>10</volume>
        <fpage>1578</fpage>
        <pub-id pub-id-type="doi">10.3389/fmicb.2019.01578</pub-id>
        <?supplied-pmid 31354672?>
        <pub-id pub-id-type="pmid">31354672</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>PRWHMDA: Human Microbe-Disease Association Prediction by Random Walk on the Heterogeneous Network with PSO</article-title>
        <source>Int J Biol Sci</source>
        <year>2018</year>
        <volume>14</volume>
        <issue>8</issue>
        <fpage>849</fpage>
        <lpage>857</lpage>
        <pub-id pub-id-type="doi">10.7150/ijbs.24539</pub-id>
        <?supplied-pmid 29989079?>
        <pub-id pub-id-type="pmid">29989079</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Noronha</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Modamio</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jarosz</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Guerard</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Sompairac</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Preciat</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The virtual metabolic human database: integrating human and gut microbiome metabolism with nutrition and disease</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D614</fpage>
        <lpage>D624</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky992</pub-id>
        <?supplied-pmid 30371894?>
        <pub-id pub-id-type="pmid">30371894</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sung</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cabatbat</surname>
            <given-names>JJT</given-names>
          </name>
          <name>
            <surname>Jang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>YS</given-names>
          </name>
          <name>
            <surname>Jung</surname>
            <given-names>GY</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Global metabolic interaction network of the human gut microbiota for context-specific community-scale analysis</article-title>
        <source>Nat Commun</source>
        <year>2017</year>
        <volume>8</volume>
        <fpage>15393</fpage>
        <pub-id pub-id-type="doi">10.1038/ncomms15393</pub-id>
        <?supplied-pmid 28585563?>
        <pub-id pub-id-type="pmid">28585563</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nelson</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Schopen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Savage</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Schulman</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Arluk</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>The MeSH translation maintenance system: structure, interface design, and implementation</article-title>
        <source>Stud Health Technol Inform</source>
        <year>2004</year>
        <volume>107</volume>
        <issue>Pt 1</issue>
        <fpage>67</fpage>
        <lpage>69</lpage>
        <?supplied-pmid 15360776?>
        <pub-id pub-id-type="pmid">15360776</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Federhen</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>The NCBI Taxonomy database</article-title>
        <source>Nucleic Acids Res</source>
        <year>2012</year>
        <volume>40</volume>
        <issue>Database issue</issue>
        <fpage> D136</fpage>
        <lpage>43</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkr1178</pub-id>
        <?supplied-pmid 22139910?>
        <pub-id pub-id-type="pmid">22139910</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gindulyte</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>PubChem in 2021: new data content and improved web interfaces</article-title>
        <source>Nucleic Acids Res</source>
        <year>2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D1388</fpage>
        <lpage>D1395</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa971</pub-id>
        <?supplied-pmid 33151290?>
        <pub-id pub-id-type="pmid">33151290</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Skoufos</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kardaras</surname>
            <given-names>FS</given-names>
          </name>
          <name>
            <surname>Alexiou</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kavakiotis</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Lambropoulou</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kotsira</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Peryton: a manual collection of experimentally supported microbe-disease associations</article-title>
        <source>Nucleic Acids Res</source>
        <year>2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D1328</fpage>
        <lpage>D1333</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa902</pub-id>
        <?supplied-pmid 33080028?>
        <pub-id pub-id-type="pmid">33080028</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Le Chatelier</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Nielsen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Qin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Prifti</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Hildebrand</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Falony</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Richness of human gut microbiome correlates with metabolic markers</article-title>
        <source>Nature</source>
        <year>2013</year>
        <volume>500</volume>
        <issue>7464</issue>
        <fpage>541</fpage>
        <lpage>546</lpage>
        <pub-id pub-id-type="doi">10.1038/nature12506</pub-id>
        <?supplied-pmid 23985870?>
        <pub-id pub-id-type="pmid">23985870</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Verhaar</surname>
            <given-names>BJH</given-names>
          </name>
          <name>
            <surname>Prodan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nieuwdorp</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Muller</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Gut microbiota in hypertension and atherosclerosis: a review</article-title>
        <source>Nutrients</source>
        <year>2020</year>
        <volume>12</volume>
        <issue>10</issue>
        <fpage>2982</fpage>
        <pub-id pub-id-type="doi">10.3390/nu12102982</pub-id>
        <?supplied-pmid 33003455?>
        <pub-id pub-id-type="pmid">33003455</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Verdin</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>NAD(+) in aging, metabolism, and neurodegeneration</article-title>
        <source>Science</source>
        <year>2015</year>
        <volume>350</volume>
        <issue>6265</issue>
        <fpage>1208</fpage>
        <lpage>1213</lpage>
        <pub-id pub-id-type="doi">10.1126/science.aac4854</pub-id>
        <?supplied-pmid 26785480?>
        <pub-id pub-id-type="pmid">26785480</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Garten</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schuster</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Penke</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gorski</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>de Giorgis</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kiess</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Physiological and pathophysiological roles of NAMPT and NAD metabolism</article-title>
        <source>Nat Rev Endocrinol</source>
        <year>2015</year>
        <volume>11</volume>
        <issue>9</issue>
        <fpage>535</fpage>
        <lpage>546</lpage>
        <pub-id pub-id-type="doi">10.1038/nrendo.2015.117</pub-id>
        <?supplied-pmid 26215259?>
        <pub-id pub-id-type="pmid">26215259</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yoshino</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mills</surname>
            <given-names>KF</given-names>
          </name>
          <name>
            <surname>Yoon</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Imai</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice</article-title>
        <source>Cell Metab</source>
        <year>2011</year>
        <volume>14</volume>
        <issue>4</issue>
        <fpage>528</fpage>
        <lpage>536</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cmet.2011.08.014</pub-id>
        <?supplied-pmid 21982712?>
        <pub-id pub-id-type="pmid">21982712</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Milne</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Lambert</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Schenk</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Carney</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Gagne</surname>
            <given-names>DJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes</article-title>
        <source>Nature</source>
        <year>2007</year>
        <volume>450</volume>
        <issue>7170</issue>
        <fpage>712</fpage>
        <lpage>716</lpage>
        <pub-id pub-id-type="doi">10.1038/nature06261</pub-id>
        <?supplied-pmid 18046409?>
        <pub-id pub-id-type="pmid">18046409</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Qiu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Gut microbiota mediate melatonin signalling in association with type 2 diabetes</article-title>
        <source>Diabetologia</source>
        <year>2022</year>
        <volume>65</volume>
        <issue>10</issue>
        <fpage>1627</fpage>
        <lpage>1641</lpage>
        <pub-id pub-id-type="doi">10.1007/s00125-022-05747-w</pub-id>
        <?supplied-pmid 35768541?>
        <pub-id pub-id-type="pmid">35768541</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Karamitri</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jockers</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Melatonin in type 2 diabetes mellitus and obesity</article-title>
        <source>Nat Rev Endocrinol</source>
        <year>2019</year>
        <volume>15</volume>
        <issue>2</issue>
        <fpage>105</fpage>
        <lpage>125</lpage>
        <pub-id pub-id-type="doi">10.1038/s41574-018-0130-1</pub-id>
        <?supplied-pmid 30531911?>
        <pub-id pub-id-type="pmid">30531911</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Agus</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Clement</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sokol</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Gut microbiota-derived metabolites as central regulators in metabolic disorders</article-title>
        <source>Gut</source>
        <year>2021</year>
        <volume>70</volume>
        <issue>6</issue>
        <fpage>1174</fpage>
        <lpage>1182</lpage>
        <pub-id pub-id-type="doi">10.1136/gutjnl-2020-323071</pub-id>
        <?supplied-pmid 33272977?>
        <pub-id pub-id-type="pmid">33272977</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oliphant</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Allen-Vercoe</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health</article-title>
        <source>Microbiome</source>
        <year>2019</year>
        <volume>7</volume>
        <issue>1</issue>
        <fpage>91</fpage>
        <pub-id pub-id-type="doi">10.1186/s40168-019-0704-8</pub-id>
        <?supplied-pmid 31196177?>
        <pub-id pub-id-type="pmid">31196177</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">BMC Genomics</journal-id>
    <journal-id journal-id-type="iso-abbrev">BMC Genomics</journal-id>
    <journal-title-group>
      <journal-title>BMC Genomics</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1471-2164</issn>
    <publisher>
      <publisher-name>BioMed Central</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">10464125</article-id>
    <article-id pub-id-type="pmid">37620754</article-id>
    <article-id pub-id-type="publisher-id">9599</article-id>
    <article-id pub-id-type="doi">10.1186/s12864-023-09599-5</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Database</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>GMMAD: a comprehensive database of human gut microbial metabolite associations with diseases</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Cheng-Yu</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kuang</surname>
          <given-names>Xia</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Wang</surname>
          <given-names>Qiao-Qiao</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Gu-Qin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Cheng</surname>
          <given-names>Zhen-Shun</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Deng</surname>
          <given-names>Zi-Xin</given-names>
        </name>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Guo</surname>
          <given-names>Feng-Biao</given-names>
        </name>
        <address>
          <email>fbguoy@whu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01v5mqw79</institution-id><institution-id institution-id-type="GRID">grid.413247.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 1808 0969</institution-id><institution>Department of Respiratory and Critical Care Medicine, </institution><institution>Zhongnan Hospital of Wuhan University, </institution></institution-wrap>Wuhan, China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/033vjfk17</institution-id><institution-id institution-id-type="GRID">grid.49470.3e</institution-id><institution-id institution-id-type="ISNI">0000 0001 2331 6153</institution-id><institution>Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education and School of Pharmaceutical Sciences, </institution><institution>Wuhan University, </institution></institution-wrap>Wuhan, China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>24</day>
      <month>8</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>24</day>
      <month>8</month>
      <year>2023</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2023</year>
    </pub-date>
    <volume>24</volume>
    <elocation-id>482</elocation-id>
    <history>
      <date date-type="received">
        <day>9</day>
        <month>2</month>
        <year>2023</year>
      </date>
      <date date-type="accepted">
        <day>17</day>
        <month>8</month>
        <year>2023</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2023</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated in a credit line to the data.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <sec>
        <title>Background</title>
        <p id="Par1">The natural products, metabolites, of gut microbes are crucial effect factors on diseases. Comprehensive identification and annotation of relationships among disease, metabolites, and microbes can provide efficient and targeted solutions towards understanding the mechanism of complex disease and development of new markers and drugs.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p id="Par2">We developed <bold>G</bold>ut <bold>M</bold>icrobial <bold>M</bold>etabolite <bold>A</bold>ssociation with <bold>D</bold>isease (GMMAD), a manually curated database of associations among human diseases, gut microbes, and metabolites of gut microbes. Here, this initial release (i) contains 3,836 disease-microbe associations and 879,263 microbe-metabolite associations, which were extracted from literatures and available resources and then experienced our manual curation; (ii) defines an association strength score and a confidence score. With these two scores, GMMAD predicted 220,690 disease-metabolite associations, where the metabolites all belong to the gut microbes. We think that the positive effective (with both scores higher than suggested thresholds) associations will help identify disease marker and understand the pathogenic mechanism from the sense of gut microbes. The negative effective associations would be taken as biomarkers and have the potential as drug candidates. Literature proofs supported our proposal with experimental consistence; (iii) provides a user-friendly web interface that allows users to browse, search, and download information on associations among diseases, metabolites, and microbes. The resource is freely available at <ext-link ext-link-type="uri" xlink:href="http://guolab.whu.edu.cn/GMMAD">http://guolab.whu.edu.cn/GMMAD</ext-link>.</p>
      </sec>
      <sec>
        <title>Conclusions</title>
        <p id="Par3">As the online-available unique resource for gut microbial metabolite-disease associations, GMMAD is helpful for researchers to explore mechanisms of disease- metabolite-microbe and screen the drug and marker candidates for different diseases.</p>
      </sec>
      <sec>
        <title>Supplementary Information</title>
        <p>The online version contains supplementary material available at 10.1186/s12864-023-09599-5.</p>
      </sec>
    </abstract>
    <kwd-group xml:lang="en">
      <title>Keywords</title>
      <kwd>Disease</kwd>
      <kwd>Metabolite</kwd>
      <kwd>Microbe</kwd>
      <kwd>Association score</kwd>
      <kwd>GMMAD database</kwd>
    </kwd-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© BioMed Central Ltd., part of Springer Nature 2023</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Background</title>
    <p id="Par4">Our gut harbours trillions of microbes which play essential roles in many physiological and pathological processes. The disturbances of gut microbiome homeostasis can cause many diseases. For example, the enrichment of <italic>Fusobacterium nucleatum</italic> can induce colorectal cancer metastasis [<xref ref-type="bibr" rid="CR1">1</xref>]. Many other diseases are also affected by microbes, such as Parkinson disease and diabetes, yet their mechanisms are still unclear [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Thanks to advances in technologies such as sequencing, we are now able to observe and analyse the composition and status of gut microbes. This can help us to diagnose diseases early and even propose new treatments based on the increase and decrease of different microbial populations in diseases [<xref ref-type="bibr" rid="CR4">4</xref>]. Although numerous studies uncover the mechanism among diseases, microbes, and metabolites, these associations are still scattered in the literature [<xref ref-type="bibr" rid="CR5">5</xref>].</p>
    <p id="Par5">In recent decades, more and more studies have shown that microbes affect human health through their metabolites [<xref ref-type="bibr" rid="CR6">6</xref>]. The metabolite is one of the key factors that drive the interaction between human gut microbes and diseases. For example, Trimethylamine N-oxide (TMAO) is a metabolite derived from the gut microbiota, which has been widely reported to be associated with cardiovascular disease [<xref ref-type="bibr" rid="CR7">7</xref>]. Recently, some studies also reported that TMAO might be a key activator of antitumor immunity [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. Another metabolite associated with cardiovascular disease is phenylacetylglutamine (PAGln). Stanley L. Hazen et al. found gut microbes that converted dietary phenylalanine into phenylacetic acid. Then, they combined with Gln and generated the PAGln. PAGln could enhance platelet activation and be associated with adverse cardiovascular events such as myocardial infarction and stroke [<xref ref-type="bibr" rid="CR10">10</xref>]. Based on these findings, the metabolites are believed to have the potential to act as drugs of various disease, and the disruption of metabolites also identified as signatures of many diseases.</p>
    <p id="Par6">Some resources focused on the association of disease-microbe or microbe-metabolite. For example, HMDAD collect text-mining-based microbe-disease associations from peer-reviewed publications [<xref ref-type="bibr" rid="CR11">11</xref>]. The current version contains 483 disease-microbe entries, which include 39 diseases and 292 microbes. The gutMDisorder is a main repository for dysbiosis of the gut microbiota in disorders and interventions, [<xref ref-type="bibr" rid="CR12">12</xref>] which contains 2,263 associations between 579 gut microbes and 123 disorders or 77 interventions in Human. The mBodyMap is a curated database for tissue microbes’ associations with diseases and health [<xref ref-type="bibr" rid="CR13">13</xref>], which contains a total of 63,148 runs, including 14,401 metagenomes and 48,747 amplicons related to health and 56 human diseases. Some researchers also developed some predicting methods to dig the potential disease-microbe associations. NTSHMDA can predict the human microbe-disease association based on random walk by integrating network topological similarity [<xref ref-type="bibr" rid="CR14">14</xref>]. ABHMDA is a model to reveal the associations between diseases and microbes by calculating the relation probability of a disease-microbe pair using a strong classifier, which can be applied to new disease without any known related microbes [<xref ref-type="bibr" rid="CR15">15</xref>]. Many other methods and models can predict disease-microbe associations [<xref ref-type="bibr" rid="CR16">16</xref>–<xref ref-type="bibr" rid="CR19">19</xref>]. On the other hand, there are a few resources that store the metabolites of microbes, such as VMH [<xref ref-type="bibr" rid="CR20">20</xref>] and NJS16 [<xref ref-type="bibr" rid="CR21">21</xref>]. However, there is still a shortage of resources of diseases’ associations with metabolites of gut microbes.</p>
    <p id="Par7">To fill this gap, we constructed the Gut Microbial Metabolite Association with Disease (GMMAD), which aims to provide users comprehensive metabolism related information of gut microbes in human diseases. Users can easily browse associations among diseases, microbes, and metabolites stored in GMMAD, and screen the potential candidate disease signatures or drugs from our predicted disease-metabolite associations (Fig. <xref rid="Fig1" ref-type="fig">1</xref>). The current version of GMMAD documents the 45,058 meaningful disease-metabolite associations which are predicted and involved with 31 diseases and 2,299 metabolites. We expect GMMAD to be a timely and valuable resource for gut microbes’ research.<fig id="Fig1"><label>Fig. 1</label><caption><p>The process of data collection and database construction. Upper part shows the process of the data collection, including manually curating literature and integrating public databases. The left panel describes our manual extraction of experimental microbe-disease information. The right panel gives the list of public databases of information source. Lower part shows the types of associations, basic information of each association entry and GMMAD functions. The left panel shows the three types of associations. Disease-metabolite is the core association, and it is provided exclusively by our database. The middle panel tells the basic information of each entry, including details of disease description, microbial category, molecular mass of metabolite and so on. The right panel provides a list of GMMAD’s main functions</p></caption><graphic xlink:href="12864_2023_9599_Fig1_HTML" id="MO1"/></fig></p>
  </sec>
  <sec id="Sec2">
    <title>Materials and methods</title>
    <sec id="Sec3">
      <title>Data collection for the first two associations</title>
      <p id="Par8">All the names of diseases in GMMAD followed the principle from the Medical Subject Heading disease categories [<xref ref-type="bibr" rid="CR22">22</xref>], and it contained 113 diseases. The annotation information of microbes was collected from the Taxonomy database [<xref ref-type="bibr" rid="CR23">23</xref>]. All the metabolites’ details were obtained from the PubChem database [<xref ref-type="bibr" rid="CR24">24</xref>]. For the association data, we integrated several public databases. The disease-microbe associations were collected from HMDAD, gutMDisorder, and Peryton [<xref ref-type="bibr" rid="CR25">25</xref>]. All data from other public databases should meet the naming standards of disease (MeSH), microbe (ncbi Taxonomy) and metabolite (PubChem). Because most of the current sequencing technologies for microbes, such as metagenomic sequencing and 16sRNA sequencing, can accurately identify only at the genus level, the microbes in our disease-microbe associations are all defined on the genus level. The microbe-metabolite associations were obtained from VMH [<xref ref-type="bibr" rid="CR20">20</xref>], NJS16 [<xref ref-type="bibr" rid="CR21">21</xref>], and the study of Han S. et al. [<xref ref-type="bibr" rid="CR6">6</xref>]. The microbes collected from VMH were in the strain level. We map the genus level of gut microbes for disease-microbe association to the strain level of metabolite-microbe association based on lineage data obtained from Taxonomy. In detail, if microbes were found to increase\decrease under the genus level in a particular disease, then it is assumed that all strains included in that genus have increased/decreased at the disease status. For example, if <italic>Faecalibacterium</italic> (in genus level) is decreased in obesity, it is assumed that the <italic>Faecalibacterium cf. prausnitzii KLE1255</italic> and <italic>Faecalibacterium prausnitzii A2-165</italic> (two strains of microbes belonging to <italic>Faecalibacterium</italic>) were both decreased in obesity. Furthermore, we used the keywords combination to search related literatures in PubMed, such as ‘gut microbiota AND cancer AND metabolites’, ‘intestinal microbiota AND diabetes AND metabolites’, etc. Then, we downloaded all published literature and available <xref rid="MOESM1" ref-type="media">supplementary files</xref> describing the associations among diseases, microbes, and metabolites. Finally, we manually extracted experimentally supported associations from selected articles by at least two researchers. For all the association, we removed the contradictory entries to ensure that the data in GMMAD were harmonious. The redundant entries stored in the GMMAD database were removed (upper part of Fig. <xref rid="Fig1" ref-type="fig">1</xref>). Values of the above two association are discrete with the first one having two directions and the latter one being “appearing” or “deficiency”. For the latter one, we only record those metabolites appearing in one specific microbe.</p>
    </sec>
    <sec id="Sec4">
      <title>Association strength score and confidence score</title>
      <p id="Par9">For the core disease-metabolite relationships, we defined one quantitative value. We supposed that common metabolites in multiple decreased numbers were beneficial to treat specific human disease, while the ones in multiple increased microbes would promote the development of that disease [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>]. We defined an association strength score to infer the association between the diseases and metabolites of gut microbes. We defined the number of microbes which increase/decrease in a specific disease as M/N, and the number of the increasing and decreasing microbes which generated a specific metabolite as m/n. The formula for the association strength score is:<disp-formula id="Equa"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{as}= \frac{m}{M}-\frac{n}{N}$$\end{document}</tex-math><mml:math id="M2" display="block"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">as</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mi>m</mml:mi><mml:mi>M</mml:mi></mml:mfrac><mml:mo>-</mml:mo><mml:mfrac><mml:mi>n</mml:mi><mml:mi>N</mml:mi></mml:mfrac></mml:mrow></mml:math><graphic xlink:href="12864_2023_9599_Article_Equa.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par10">Meanwhile, we defined a confidence score to judge the credibility of association strength scores:<disp-formula id="Equb"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{ac}=\left(m+n\right)*\left|{S}_{as}\right|$$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">ac</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfenced close=")" open="("><mml:mi>m</mml:mi><mml:mo>+</mml:mo><mml:mi>n</mml:mi></mml:mfenced><mml:mrow/><mml:mo>∗</mml:mo><mml:mfenced close="|" open="|"><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">as</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mrow></mml:math><graphic xlink:href="12864_2023_9599_Article_Equb.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par11">Because the microbial levels in the two associations were inconsistent (disease-microbe with genus level and microbe-metabolite with strain level), we used the affiliation data of microbial lineage (finally, microbe in strain level) to establish the association. <inline-formula id="IEq1"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{\mathrm{as}}$$\end{document}</tex-math><mml:math id="M6"><mml:msub><mml:mi>S</mml:mi><mml:mi mathvariant="normal">as</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12864_2023_9599_Article_IEq1.gif"/></alternatives></inline-formula> of three and five diseases are all 1 and -1, respectively. After checking, it was found that only one microbe associated with these diseases, such as ‘Colitis, Microscopic’ and ‘Gastroesophageal Reflux’. <inline-formula id="IEq2"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{\mathrm{as}}$$\end{document}</tex-math><mml:math id="M8"><mml:msub><mml:mi>S</mml:mi><mml:mi mathvariant="normal">as</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="12864_2023_9599_Article_IEq2.gif"/></alternatives></inline-formula> simulated the abundant alternation of a specific metabolite by counting the increasing or decreasing number of microbial strains in a disease sample compared to a normal sample’s gut. If a metabolite appears in only decreased microbes, its association score <inline-formula id="IEq3"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${S}_{ac}$$\end{document}</tex-math><mml:math id="M10"><mml:msub><mml:mi>S</mml:mi><mml:mrow><mml:mi mathvariant="italic">ac</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="12864_2023_9599_Article_IEq3.gif"/></alternatives></inline-formula> will have a very large negative value and in principle, it will be beneficial for the treatment of the disease or at least strongly associated with the disease. Hence, a strong positive correlation score indicated that the metabolite might be considered as a potential marker of disease, while a strong negative correlation score indicated that the metabolite might be a candidate drug for disease or potential diagnostic marker. We only considered those with the absolute value of association strength score &gt; 0.05 and confidence score &gt; 1 to be meaningful.</p>
    </sec>
    <sec id="Sec5">
      <title>Database construction</title>
      <p id="Par12">Finally, all data in GMMAD are stored and managed using MySQL (version 5.6.50). The web interfaces were built in HTML/CSS/JS on Linux and Apache platform. The data processing programs are written in Python (version 2.7.5). The GMMAD has been tested in the Google Chrome (version 104.0.5112.81) and Firefox (version 101.0.1) browsers. The GMMAD database is freely available at <ext-link ext-link-type="uri" xlink:href="http://guolab.whu.edu.cn/GMMAD">http://guolab.whu.edu.cn/GMMAD</ext-link>.</p>
    </sec>
  </sec>
  <sec id="Sec6">
    <title>Results</title>
    <sec id="Sec7">
      <title>Database content</title>
      <p id="Par13">With our method, we predicted 220,690 entries of disease-metabolite associations, the confidence scores are distributed from -1 to 1 (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Integrating and compiling all the associations we obtained from public databases and papers, GMMAD contains 3,836 disease-microbe associations and 879,263 microbe-metabolite associations which involve 113 diseases, 893 gut microbes, and 2,448 metabolites of gut microbes (Fig. <xref rid="Fig3" ref-type="fig">3</xref>A). Finally, there are 45,058 meaningful disease-metabolite associations by scoring prediction, which involve 31 diseases and 2,299 metabolites. Since each microbe produces thousands of metabolites and each disease has hundreds of associated microbes, the number of associations for the three elements disease-microbe-metabolite is huge. Showing all these associations is not helpful for user search, and it is hard for database maintenance. Thus, GMMAD only shows associations between any two of the three terms: disease, microbe and metabolite. For each entry, GMMAD restored the human disease name (e.g. Crohn disease), microbe name (e.g. <italic>Faecalibacterium</italic>), metabolite name (e.g. Actinomyces georgiae DSM 6843), alteration pattern (e.g. increase and decrease), the experimental method (e.g. 16S rRNA sequences), alteration strength score and confidence score of disease-metabolite associations, disease detail (e.g. disease description), metabolite information (e.g. charged formula, average molecular mass), and microbe information. The ID of disease, microbe, metabolite and PMID were also provided which could be linked to MeSH, Taxonomy, PubChem and PubMed for more details.<fig id="Fig2"><label>Fig. 2</label><caption><p>Distribution of association strength scores in 113 different diseases. Diseases were shown in the deceasing order of the mean <italic>S</italic><sub><italic>as</italic></sub> of associated metabolites</p></caption><graphic xlink:href="12864_2023_9599_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Statistic of data in GMMAD. <bold>A</bold> The number of diseases, microbes and metabolites in GMMAD. <bold>B</bold> The top 10 diseases in disease-microbe associations. <bold>C</bold> The top 10 microbes in disease-microbe associations. <bold>D</bold> The top 10 microbes in microbe-metabolite associations. <bold>E</bold> The top 10 metabolite s in microbe-metabolite associations</p></caption><graphic xlink:href="12864_2023_9599_Fig3_HTML" id="MO3"/></fig></p>
      <p id="Par14">Figure <xref rid="Fig3" ref-type="fig">3</xref>B-E show the top 10 diseases, microbes, and metabolites in the different types of associations. The colorectal neoplasm is the disease with the most entries (Fig. <xref rid="Fig3" ref-type="fig">3</xref>B). This suggested that colorectal neoplasm is closely connected to gut microbes and their metabolites. <italic>Bacteroides</italic> are the microbe which associated with the most diseases (Fig. <xref rid="Fig3" ref-type="fig">3</xref>C). In addition, <italic>Yokenella regensburgei ATCC 43003</italic> and ala_L (L-Alanine) are the microbe and metabolite with the most entries in microbe-metabolite associations (Fig. <xref rid="Fig3" ref-type="fig">3</xref>D, E)<italic>.</italic></p>
    </sec>
    <sec id="Sec8">
      <title>GMMAD implementation</title>
      <p id="Par15">The GMMAD provides a user-friendly interface that allows users to browse, search, and download (lower part of Fig. <xref rid="Fig1" ref-type="fig">1</xref>). The tree browser organizes the data according to three types of associations: “Disease-Metabolite”, “Disease-Microbe” and “Microbe-Metabolite”. Each type of root category is divided into several sub-categories named “Disease”, “Metabolite”, “Microbe” and “Validated associations” (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). By clicking one term in these sub-categories, all associations belonging to the corresponding term would be listed on the right table. On the ‘Search’ page, users can search associations according to name and ID of diseases, microbes, and metabolites (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). Example names for searching are provided when users click the “Example” on the bottom of each search box. In the results table, users can click the icon in the upper right corner to download the search results. The ‘Detail’ link of each entry leads to the more detailed information including the microbes’ family, description of diseases, formula of metabolites, samples information and so on (Fig. <xref rid="Fig4" ref-type="fig">4</xref>). The ‘Download’ page allows users to download all information on disease-metabolite, disease-microbe and microbe-metabolite associations data in.txt format. GMMAD also provides external links to the related public databases. All tutorials and details are shown in the ‘Help’ page.<fig id="Fig4"><label>Fig. 4</label><caption><p>Schematic workflow of GMMAD. Browse part: User can browse all three types of association data in GMMAD. Search part: User can search the interested association by typing the key word. Results part: All the results will be shown in the table which includes information about each term. Details part: User can click ‘Detail’ to obtain more details about disease, microbe, and metabolite</p></caption><graphic xlink:href="12864_2023_9599_Fig4_HTML" id="MO4"/></fig></p>
    </sec>
    <sec id="Sec9">
      <title>Validation of predicted disease-metabolite association</title>
      <p id="Par16">To prioritize and filter the meaning of disease-metabolite association and reveal the most interesting results, we defined an association strength score and a confidence score. As a rough evaluation of the accuracy of our method, we got 138 experimental disease-metabolite association from 49 published studies. Among them, 36 associations have meaning scores and 26 (72.2%) could be given consistent direction of disease-metabolite association (Supplementary table <xref rid="MOESM1" ref-type="media">1</xref>). We do not aim to pick out all the disease-metabolites associations, and our main purpose is to make our chosen association genuine in high probability and deserved to be studied as drug or marker candidates.</p>
      <p id="Par17">For example, by querying “Diabetes Mellitus, Type 2” (T2DM) in the “Search (Disease-Metabolite)” query box, GMMAD provides the 2137 T2DM associated metabolites. Each entry has an association strength score and a confidence score, which the user can browse in order of score value. For example, we sort all the “Diabetes Mellitus, Type 2” related entries according to their association strength scores, and the “nadide” is the third strongest negative association score with the T2DM (<italic>S</italic><sub><italic>as</italic></sub> = -0.625 and <italic>S</italic><sub><italic>ac</italic></sub> = 3.13). Nadide (also called NAD + , Nicotinamide Adenine Dinucleotide) is an indispensable enzyme in the human body and an important coenzyme in the tricarboxylic acid cycle. It plays a crucial role in various biological processes such as human metabolism, stress, and cell differentiation. In patients with T2DM, NAD + synthesis is severely impaired [<xref ref-type="bibr" rid="CR28">28</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]. Many researchers are trying to promote the synthesis of NAD + as a treatment for patients with type 2 diabetes mellitus, and several drugs based on this mechanism have been developed [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Similarly, the “Melatonin” is the fifth strongest negative association score with the T2DM (S<sub>as</sub> = -0.500 and S<sub>ac</sub> = 2.00). Melatonin is well known for its sleep-promoting effects. In recent years, studies had found that melatonin has a certain hypoglycaemic effect, and its mechanism might be related to improving insulin resistance, protecting pancreatic β-cells, and regulating the hypothalamus–pituitary–adrenal axis. These findings reveal the importance of melatonin and melatonin-related bacteria and metabolites as potential therapeutic targets for type 2 diabetes [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. All of these demonstrate that our method can effectively expose the useful disease-metabolite associations.</p>
    </sec>
  </sec>
  <sec id="Sec10">
    <title>Discussion</title>
    <p id="Par18">Despite a lot of research on the association between gut microbes and diseases, the mechanism of gut microbes in various diseases is still unclear. In recent years, more and more researchers have found that gut microbes affect through their metabolites in diseases [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>].</p>
    <p id="Par19">Currently, there are many disease-microbe databases have been built, such as HMDAD [<xref ref-type="bibr" rid="CR11">11</xref>], gutMDisorder [<xref ref-type="bibr" rid="CR12">12</xref>] and Peryton [<xref ref-type="bibr" rid="CR25">25</xref>]. To the best of our knowledge, none of these databases focuses on the association data of disease and metabolites of gut microbes. However, the current version of our GMMAD contains 45,058 meaningful disease-metabolite associations.</p>
    <p id="Par20">As the resource uniquely stores the quantitative association of disease and gut microbes’ metabolites, GMMAD will suggest potential markers and drugs for specific diseases. When used as drug candidates for these metabolites, the safety of these candidates will be less concerning than usual drug candidates because they naturally exist in the human gut environment. Simultaneously, the association due to their predictive essence should be experimentally validated by the research in practical application. The role of our database is to pick out those most possible drug and biomarker candidate from the gut microbes’ metabolites and ranked them with quantitative scores. By referencing our database, the experimental scientists have the refined candidates in their hands, and they deserve to pay more attention. With the accumulation of data, the one sense is the promotion of associations between the disease and microbial strains, the other sense is that the metabolome research could provide more reliable microbe-metabolite associations. We will update the database with a higher quality list of associations between specific disease and metabolites of gut microbes. In the future, besides the content update, more features will be added to the database, such as the ability to search for broad chemical classes of compounds beyond specific compounds. Meanwhile, we will provide visualization tools for showing the associations network.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <sec id="Sec11">
      <title>Supplementary Information</title>
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="12864_2023_9599_MOESM1_ESM.docx">
            <caption>
              <p><bold>Additional file 1: </bold><bold>Supplementary Table 1.</bold> Predictive scores of experimentally validated disease-metabolite association data.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher’s Note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <ack>
    <title>Acknowledgements</title>
    <p>Not applicable.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Authors’ contributions</title>
    <p>FBG conceived the study and guided it throughout and revised the manuscript. CYW, XK, and QQW performed the dataset collection. CYW compiled the codes for the database and prepared the figures and tables and wrote the first draft of the manuscript. GQZ, ZSC and ZXD contributed to the review of the manuscript before submission. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="funding-information">
    <title>Funding</title>
    <p>This study was supported by the National Key Research and Development Program [2018YFA0903702].</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Availability of data and materials</title>
    <p>GMMAD is publicly available: <ext-link ext-link-type="uri" xlink:href="http://guolab.whu.edu.cn/GMMAD">http://guolab.whu.edu.cn/GMMAD</ext-link>.</p>
  </notes>
  <notes>
    <title>Declarations</title>
    <notes id="FPar1">
      <title>Ethics approval and consent to participate</title>
      <p id="Par21">Not applicable.</p>
    </notes>
    <notes id="FPar2" notes-type="COI-statement">
      <title>Competing interests</title>
      <p id="Par22">The authors declare no competing interests.</p>
    </notes>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Ge</surname>
            <given-names>Q</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS/KRT7</article-title>
        <source>Gut Microbes</source>
        <year>2020</year>
        <volume>11</volume>
        <issue>3</issue>
        <fpage>511</fpage>
        <lpage>525</lpage>
        <pub-id pub-id-type="doi">10.1080/19490976.2019.1695494</pub-id>
        <?supplied-pmid 31910722?>
        <pub-id pub-id-type="pmid">31910722</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Massey</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Brown</surname>
            <given-names>JM</given-names>
          </name>
        </person-group>
        <article-title>The gut microbial endocrine organ in type 2 diabetes</article-title>
        <source>Endocrinology</source>
        <year>2021</year>
        <volume>162</volume>
        <issue>2</issue>
        <fpage>bqaa235</fpage>
        <pub-id pub-id-type="doi">10.1210/endocr/bqaa235</pub-id>
        <?supplied-pmid 33373432?>
        <pub-id pub-id-type="pmid">33373432</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tan</surname>
            <given-names>AH</given-names>
          </name>
          <name>
            <surname>Lim</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Lang</surname>
            <given-names>AE</given-names>
          </name>
        </person-group>
        <article-title>The microbiome-gut-brain axis in Parkinson disease - from basic research to the clinic</article-title>
        <source>Nat Rev Neurol</source>
        <year>2022</year>
        <volume>18</volume>
        <issue>8</issue>
        <fpage>476</fpage>
        <lpage>495</lpage>
        <pub-id pub-id-type="doi">10.1038/s41582-022-00681-2</pub-id>
        <?supplied-pmid 35750883?>
        <pub-id pub-id-type="pmid">35750883</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Role and Mechanism of Gut Microbiota in Human Disease</article-title>
        <source>Front Cell Infect Microbiol</source>
        <year>2021</year>
        <volume>11</volume>
        <fpage>625913</fpage>
        <pub-id pub-id-type="doi">10.3389/fcimb.2021.625913</pub-id>
        <?supplied-pmid 33816335?>
        <pub-id pub-id-type="pmid">33816335</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dang</surname>
            <given-names>AT</given-names>
          </name>
          <name>
            <surname>Marsland</surname>
            <given-names>BJ</given-names>
          </name>
        </person-group>
        <article-title>Microbes, metabolites, and the gut-lung axis</article-title>
        <source>Mucosal Immunol</source>
        <year>2019</year>
        <volume>12</volume>
        <issue>4</issue>
        <fpage>843</fpage>
        <lpage>850</lpage>
        <pub-id pub-id-type="doi">10.1038/s41385-019-0160-6</pub-id>
        <?supplied-pmid 30976087?>
        <pub-id pub-id-type="pmid">30976087</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Han</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Van Treuren</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Fischer</surname>
            <given-names>CR</given-names>
          </name>
          <name>
            <surname>Merrill</surname>
            <given-names>BD</given-names>
          </name>
          <name>
            <surname>DeFelice</surname>
            <given-names>BC</given-names>
          </name>
          <name>
            <surname>Sanchez</surname>
            <given-names>JM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A metabolomics pipeline for the mechanistic interrogation of the gut microbiome</article-title>
        <source>Nature</source>
        <year>2021</year>
        <volume>595</volume>
        <issue>7867</issue>
        <fpage>415</fpage>
        <lpage>420</lpage>
        <pub-id pub-id-type="doi">10.1038/s41586-021-03707-9</pub-id>
        <?supplied-pmid 34262212?>
        <pub-id pub-id-type="pmid">34262212</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Klipfell</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Bennett</surname>
            <given-names>BJ</given-names>
          </name>
          <name>
            <surname>Koeth</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Levison</surname>
            <given-names>BS</given-names>
          </name>
          <name>
            <surname>Dugar</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease</article-title>
        <source>Nature</source>
        <year>2011</year>
        <volume>472</volume>
        <issue>7341</issue>
        <fpage>57</fpage>
        <lpage>63</lpage>
        <pub-id pub-id-type="doi">10.1038/nature09922</pub-id>
        <?supplied-pmid 21475195?>
        <pub-id pub-id-type="pmid">21475195</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Rong</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Xiao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The microbial metabolite trimethylamine N-oxide promotes antitumor immunity in triple-negative breast cancer</article-title>
        <source>Cell Metab</source>
        <year>2022</year>
        <volume>34</volume>
        <issue>4</issue>
        <fpage>581</fpage>
        <lpage>94 e8</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cmet.2022.02.010</pub-id>
        <?supplied-pmid 35278352?>
        <pub-id pub-id-type="pmid">35278352</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mirji</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Worth</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Bhat</surname>
            <given-names>SA</given-names>
          </name>
          <name>
            <surname>El Sayed</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Kannan</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Goldman</surname>
            <given-names>AR</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The microbiome-derived metabolite TMAO drives immune activation and boosts responses to immune checkpoint blockade in pancreatic cancer</article-title>
        <source>Sci Immunol</source>
        <year>2022</year>
        <volume>7</volume>
        <issue>75</issue>
        <fpage>eabn0704</fpage>
        <pub-id pub-id-type="doi">10.1126/sciimmunol.abn0704</pub-id>
        <?supplied-pmid 36083892?>
        <pub-id pub-id-type="pmid">36083892</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nemet</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Saha</surname>
            <given-names>PP</given-names>
          </name>
          <name>
            <surname>Gupta</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Romano</surname>
            <given-names>KA</given-names>
          </name>
          <name>
            <surname>Skye</surname>
            <given-names>SM</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A cardiovascular disease-linked gut microbial metabolite acts via adrenergic receptors</article-title>
        <source>Cell</source>
        <year>2020</year>
        <volume>180</volume>
        <issue>5</issue>
        <fpage>862</fpage>
        <lpage>7722</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cell.2020.02.016</pub-id>
        <?supplied-pmid 32142679?>
        <pub-id pub-id-type="pmid">32142679</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ma</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Geng</surname>
            <given-names>B</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>An analysis of human microbe-disease associations</article-title>
        <source>Brief Bioinform</source>
        <year>2017</year>
        <volume>18</volume>
        <issue>1</issue>
        <fpage>85</fpage>
        <lpage>97</lpage>
        <pub-id pub-id-type="doi">10.1093/bib/bbw005</pub-id>
        <?supplied-pmid 26883326?>
        <pub-id pub-id-type="pmid">26883326</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cheng</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Qi</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zhuang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>gutMDisorder: a comprehensive database for dysbiosis of the gut microbiota in disorders and interventions</article-title>
        <source>Nucleic Acids Res</source>
        <year>2020</year>
        <volume>48</volume>
        <issue>D1</issue>
        <fpage>D554</fpage>
        <lpage>D560</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkz843</pub-id>
        <?supplied-pmid 31584099?>
        <pub-id pub-id-type="pmid">31584099</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>mBodyMap: a curated database for microbes across human body and their associations with health and diseases</article-title>
        <source>Nucleic Acids Res</source>
        <year>2022</year>
        <volume>50</volume>
        <issue>D1</issue>
        <fpage>D808</fpage>
        <lpage>D816</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkab973</pub-id>
        <?supplied-pmid 34718713?>
        <pub-id pub-id-type="pmid">34718713</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Luo</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Long</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>NTSHMDA: prediction of human microbe-disease association based on random walk by integrating network topological similarity</article-title>
        <source>IEEE/ACM Trans Comput Biol Bioinform</source>
        <year>2020</year>
        <volume>17</volume>
        <issue>4</issue>
        <fpage>1341</fpage>
        <lpage>1351</lpage>
        <?supplied-pmid 30489271?>
        <pub-id pub-id-type="pmid">30489271</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Peng</surname>
            <given-names>LH</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>MX</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Human Microbe-Disease Association Prediction Based on Adaptive Boosting</article-title>
        <source>Front Microbiol</source>
        <year>2018</year>
        <volume>9</volume>
        <fpage>2440</fpage>
        <pub-id pub-id-type="doi">10.3389/fmicb.2018.02440</pub-id>
        <?supplied-pmid 30356751?>
        <pub-id pub-id-type="pmid">30356751</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zou</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>A novel approach for predicting microbe-disease associations by bi-random walk on the heterogeneous network</article-title>
        <source>PLoS ONE</source>
        <year>2017</year>
        <volume>12</volume>
        <issue>9</issue>
        <fpage>e0184394</fpage>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0184394</pub-id>
        <?supplied-pmid 28880967?>
        <pub-id pub-id-type="pmid">28880967</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>JF</given-names>
          </name>
        </person-group>
        <article-title>Prediction of microbe-disease associations by graph regularized non-negative matrix factorization</article-title>
        <source>J Comput Biol</source>
        <year>2018</year>
        <volume>25</volume>
        <issue>12</issue>
        <fpage>1385</fpage>
        <lpage>1394</lpage>
        <pub-id pub-id-type="doi">10.1089/cmb.2018.0072</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Niu</surname>
            <given-names>YW</given-names>
          </name>
          <name>
            <surname>Qu</surname>
            <given-names>CQ</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>GH</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>GY</given-names>
          </name>
        </person-group>
        <article-title>RWHMDA: Random Walk on Hypergraph for Microbe-Disease Association Prediction</article-title>
        <source>Front Microbiol</source>
        <year>2019</year>
        <volume>10</volume>
        <fpage>1578</fpage>
        <pub-id pub-id-type="doi">10.3389/fmicb.2019.01578</pub-id>
        <?supplied-pmid 31354672?>
        <pub-id pub-id-type="pmid">31354672</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>PRWHMDA: Human Microbe-Disease Association Prediction by Random Walk on the Heterogeneous Network with PSO</article-title>
        <source>Int J Biol Sci</source>
        <year>2018</year>
        <volume>14</volume>
        <issue>8</issue>
        <fpage>849</fpage>
        <lpage>857</lpage>
        <pub-id pub-id-type="doi">10.7150/ijbs.24539</pub-id>
        <?supplied-pmid 29989079?>
        <pub-id pub-id-type="pmid">29989079</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Noronha</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Modamio</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jarosz</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Guerard</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Sompairac</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Preciat</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>The virtual metabolic human database: integrating human and gut microbiome metabolism with nutrition and disease</article-title>
        <source>Nucleic Acids Res</source>
        <year>2019</year>
        <volume>47</volume>
        <issue>D1</issue>
        <fpage>D614</fpage>
        <lpage>D624</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gky992</pub-id>
        <?supplied-pmid 30371894?>
        <pub-id pub-id-type="pmid">30371894</pub-id>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sung</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cabatbat</surname>
            <given-names>JJT</given-names>
          </name>
          <name>
            <surname>Jang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>YS</given-names>
          </name>
          <name>
            <surname>Jung</surname>
            <given-names>GY</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Global metabolic interaction network of the human gut microbiota for context-specific community-scale analysis</article-title>
        <source>Nat Commun</source>
        <year>2017</year>
        <volume>8</volume>
        <fpage>15393</fpage>
        <pub-id pub-id-type="doi">10.1038/ncomms15393</pub-id>
        <?supplied-pmid 28585563?>
        <pub-id pub-id-type="pmid">28585563</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nelson</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Schopen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Savage</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>Schulman</surname>
            <given-names>JL</given-names>
          </name>
          <name>
            <surname>Arluk</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>The MeSH translation maintenance system: structure, interface design, and implementation</article-title>
        <source>Stud Health Technol Inform</source>
        <year>2004</year>
        <volume>107</volume>
        <issue>Pt 1</issue>
        <fpage>67</fpage>
        <lpage>69</lpage>
        <?supplied-pmid 15360776?>
        <pub-id pub-id-type="pmid">15360776</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Federhen</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>The NCBI Taxonomy database</article-title>
        <source>Nucleic Acids Res</source>
        <year>2012</year>
        <volume>40</volume>
        <issue>Database issue</issue>
        <fpage> D136</fpage>
        <lpage>43</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkr1178</pub-id>
        <?supplied-pmid 22139910?>
        <pub-id pub-id-type="pmid">22139910</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gindulyte</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>PubChem in 2021: new data content and improved web interfaces</article-title>
        <source>Nucleic Acids Res</source>
        <year>2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D1388</fpage>
        <lpage>D1395</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa971</pub-id>
        <?supplied-pmid 33151290?>
        <pub-id pub-id-type="pmid">33151290</pub-id>
      </element-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Skoufos</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Kardaras</surname>
            <given-names>FS</given-names>
          </name>
          <name>
            <surname>Alexiou</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kavakiotis</surname>
            <given-names>I</given-names>
          </name>
          <name>
            <surname>Lambropoulou</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Kotsira</surname>
            <given-names>V</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Peryton: a manual collection of experimentally supported microbe-disease associations</article-title>
        <source>Nucleic Acids Res</source>
        <year>2021</year>
        <volume>49</volume>
        <issue>D1</issue>
        <fpage>D1328</fpage>
        <lpage>D1333</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkaa902</pub-id>
        <?supplied-pmid 33080028?>
        <pub-id pub-id-type="pmid">33080028</pub-id>
      </element-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Le Chatelier</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Nielsen</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Qin</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Prifti</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Hildebrand</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Falony</surname>
            <given-names>G</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Richness of human gut microbiome correlates with metabolic markers</article-title>
        <source>Nature</source>
        <year>2013</year>
        <volume>500</volume>
        <issue>7464</issue>
        <fpage>541</fpage>
        <lpage>546</lpage>
        <pub-id pub-id-type="doi">10.1038/nature12506</pub-id>
        <?supplied-pmid 23985870?>
        <pub-id pub-id-type="pmid">23985870</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Verhaar</surname>
            <given-names>BJH</given-names>
          </name>
          <name>
            <surname>Prodan</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Nieuwdorp</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Muller</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Gut microbiota in hypertension and atherosclerosis: a review</article-title>
        <source>Nutrients</source>
        <year>2020</year>
        <volume>12</volume>
        <issue>10</issue>
        <fpage>2982</fpage>
        <pub-id pub-id-type="doi">10.3390/nu12102982</pub-id>
        <?supplied-pmid 33003455?>
        <pub-id pub-id-type="pmid">33003455</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Verdin</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>NAD(+) in aging, metabolism, and neurodegeneration</article-title>
        <source>Science</source>
        <year>2015</year>
        <volume>350</volume>
        <issue>6265</issue>
        <fpage>1208</fpage>
        <lpage>1213</lpage>
        <pub-id pub-id-type="doi">10.1126/science.aac4854</pub-id>
        <?supplied-pmid 26785480?>
        <pub-id pub-id-type="pmid">26785480</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Garten</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Schuster</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Penke</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Gorski</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>de Giorgis</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Kiess</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>Physiological and pathophysiological roles of NAMPT and NAD metabolism</article-title>
        <source>Nat Rev Endocrinol</source>
        <year>2015</year>
        <volume>11</volume>
        <issue>9</issue>
        <fpage>535</fpage>
        <lpage>546</lpage>
        <pub-id pub-id-type="doi">10.1038/nrendo.2015.117</pub-id>
        <?supplied-pmid 26215259?>
        <pub-id pub-id-type="pmid">26215259</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yoshino</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Mills</surname>
            <given-names>KF</given-names>
          </name>
          <name>
            <surname>Yoon</surname>
            <given-names>MJ</given-names>
          </name>
          <name>
            <surname>Imai</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice</article-title>
        <source>Cell Metab</source>
        <year>2011</year>
        <volume>14</volume>
        <issue>4</issue>
        <fpage>528</fpage>
        <lpage>536</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cmet.2011.08.014</pub-id>
        <?supplied-pmid 21982712?>
        <pub-id pub-id-type="pmid">21982712</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Milne</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Lambert</surname>
            <given-names>PD</given-names>
          </name>
          <name>
            <surname>Schenk</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Carney</surname>
            <given-names>DP</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>JJ</given-names>
          </name>
          <name>
            <surname>Gagne</surname>
            <given-names>DJ</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes</article-title>
        <source>Nature</source>
        <year>2007</year>
        <volume>450</volume>
        <issue>7170</issue>
        <fpage>712</fpage>
        <lpage>716</lpage>
        <pub-id pub-id-type="doi">10.1038/nature06261</pub-id>
        <?supplied-pmid 18046409?>
        <pub-id pub-id-type="pmid">18046409</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Qiu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>Z</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Gut microbiota mediate melatonin signalling in association with type 2 diabetes</article-title>
        <source>Diabetologia</source>
        <year>2022</year>
        <volume>65</volume>
        <issue>10</issue>
        <fpage>1627</fpage>
        <lpage>1641</lpage>
        <pub-id pub-id-type="doi">10.1007/s00125-022-05747-w</pub-id>
        <?supplied-pmid 35768541?>
        <pub-id pub-id-type="pmid">35768541</pub-id>
      </element-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Karamitri</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Jockers</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>Melatonin in type 2 diabetes mellitus and obesity</article-title>
        <source>Nat Rev Endocrinol</source>
        <year>2019</year>
        <volume>15</volume>
        <issue>2</issue>
        <fpage>105</fpage>
        <lpage>125</lpage>
        <pub-id pub-id-type="doi">10.1038/s41574-018-0130-1</pub-id>
        <?supplied-pmid 30531911?>
        <pub-id pub-id-type="pmid">30531911</pub-id>
      </element-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Agus</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Clement</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Sokol</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Gut microbiota-derived metabolites as central regulators in metabolic disorders</article-title>
        <source>Gut</source>
        <year>2021</year>
        <volume>70</volume>
        <issue>6</issue>
        <fpage>1174</fpage>
        <lpage>1182</lpage>
        <pub-id pub-id-type="doi">10.1136/gutjnl-2020-323071</pub-id>
        <?supplied-pmid 33272977?>
        <pub-id pub-id-type="pmid">33272977</pub-id>
      </element-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Oliphant</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Allen-Vercoe</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>Macronutrient metabolism by the human gut microbiome: major fermentation by-products and their impact on host health</article-title>
        <source>Microbiome</source>
        <year>2019</year>
        <volume>7</volume>
        <issue>1</issue>
        <fpage>91</fpage>
        <pub-id pub-id-type="doi">10.1186/s40168-019-0704-8</pub-id>
        <?supplied-pmid 31196177?>
        <pub-id pub-id-type="pmid">31196177</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
